Literature DB >> 26848196

Clinical Aspects associated with Syndromic forms of Orofacial Clefts in a Colombian population.

Liliana Arias Urueña1, Ignacio Briceño Balcazar2, Julio Martinez Lozano1, Andrew Collins3, Daniel Alfredo Uricoechea Patiño1.   

Abstract

OBJECTIVES: To present descriptive epidemiology of Orofacial Clefts and to determine the association of syndromic forms with antenatal high-risk conditions, preterm birth, and comorbidities among nested-series of cases.
METHODS: A study of nested-series of cases was conducted. Frequencies of cleft type, associated congenital anomalies, syndromic, non-syndromic and multiple malformation forms, and distribution of Orofacial Clefts according to sex and affected-side were determined. Odds ratios were calculated as measures of association between syndromic forms and antenatal high-risk conditions, preterm birth and comorbidities. A total of three hundred and eleven patients with Orofacial Clefts were assessed in a 12-month period.
RESULTS: The most frequent type of Orofacial Clefts was cleft lip and palate, this type of cleft was more frequent in males, whereas cleft palate occurred more often in females. The most common cases occurred as non-syndromic forms. Aarskog-Scott syndrome showed the highest frequency amongst syndromic forms. Hypertensive disorders in pregnancy, developmental dysplasia of the hip, central nervous diseases and respiratory failure showed significant statistical associations (p <0.05) with syndromic forms.
CONCLUSIONS: These data provide an epidemiological reference of Orofacial Clefts in Colombia. Novel associations between syndromic forms and clinical variables are determined. In order to investigate causality relationships between these variables further studies must be carried out.

Entities:  

Keywords:  Aarskog-Scott syndrome; Cleft lip and palate; Congenital Hip Dysplasia; Pre-eclampsia

Mesh:

Year:  2015        PMID: 26848196      PMCID: PMC4732505     

Source DB:  PubMed          Journal:  Colomb Med (Cali)        ISSN: 0120-8322


Introduction

Orofacial clefts (OFC) represent one of the most common birth defects, occurring frequently in Asians and Amerindians 1-3. Affected subjects tend to have language and hearing problems and difficulty in social integration, therefore multidisciplinary care is required in order to improve health status 4. Based on their association with specific malformative patterns or their presence as isolated defects, OFCs can be classified as syndromic (SF) and nonsyndromic form (NSF), respectively 5. Approximately 30% of cases of Cleft Lip and Palate (CLP) occur as SF 6,7. Patients affected by SF tend to have higher morbidity and mortality throughout life due to their associated congenital anomalies 4. Given the complex etiology and pathogenesis of these anomalies, patients need genetic assessment to establish an accurate diagnosis and appropriate risk management 8. The prevalence of OFCs depends largely on factors such as ethnicity and geographic region 9. Frequently, facial clefts are associated with other congenital defects 4,10. The study of past medical and family history and associated anomalies is useful in understanding inheritance patterns, risk factors and in providing public health strategies 8. No research in Colombia has addressed a complete descriptive epidemiology of OFC or the relationship of OFC with some clinical aspects 11,12, therefore providing epidemiological information is a research priority area. The current study was designed to: 1) present the frequency of cleft type, associated congenital anomalies, syndromic, non-syndromic and multiple malformation forms; 2) determinate associations between syndromic forms and antenatal high- risk conditions, preterm birth and comorbidities.

Materials and Methods

Subjects

Three hundred and eleven individuals with Orofacial Clefts aged between 3 weeks and 52 yrs who attended at Operation Smile Colombia from April 2012 to July 2013 were assessed by Medical Genetics Team at Operation Smile Colombia. A recruiting was not performed. The whole population was included in this study. Sampling was not carried out. 168 (52%) were males, 149 (48%) were females. Distribution by age is shown in Table 1. Ethical principles for medical research involving human subjects, as outlined in the declaration of Helsinki were followed. Universidad de La Sabana ethical committee approved the study protocol.
Table 1.

Sex, age and region of origin (N= 311).

Variable n%
SexMale16854
Female14948
Age range (yrs)<1 m72
<110534
2-5 4113
6-115016
12-175819
≥185016
Origin areaRural13744
Urban17456

m= month

m= month

Procedure

Information about sex, type of cleft, past medical and family history was recorded in children (<18 yrs) and adults (≥18 yrs). In children, maternal, and pediatric history were recorded focusing on antenatal high-risk conditions, the presence or absence of preterm birth, comorbidities and neonatal diseases. Pregnancy dietary supplements and /or folate intakes were not assessed. Preterm birth was defined as delivery at ≤37 weeks gestation. Two trained physicians in clinical genetics performed a physical examination focusing on identifying other congenital anomalies and establishing a clinical diagnosis. Based on clinical features the patients were classified into 3 categories: 1. Non- syndromic form (NSF): patients affected by isolated OFCs. 2. Syndromic form (SF): patients affected by OFCs and a specific syndrome can be recognized (OMIM). 3. Multiple malformation form (MMF): patients affected by OFCs and other malformations but a specific syndrome cannot be recognized. 4. A whole-exome sequencing was used to resolve clinical diagnoses for some syndromic phenotypes.

Data analysis

Cross tabulation was used to analyze the frequency distribution of the variables (sex, age, region of origin, cleft type, affected-side, clinical form, associate anomalies, morbidities). In order to determinate a measure of association between the occurrences of interest (antenatal high-risk conditions, presence or absence of preterm birth, and comorbidities) and SF of OFC, two cases were defined. Case 1: cases with SF (224). Case 2: cases with NSF (59). Taking into account MMF does not have any specific pattern it was not included in any case group. Chi-square statistics, Fisher´s exact test and odds ratio (OR) calculations were used to determine associations. The frequency of the ocurrences in SF group to NSF group was compared. Results were considered to be significant at p <0.05. All data were analyzed using Epi Info version 7® 13.

Results

The most common sex, age range and region of origin were male, 1-23 months and urban area respectively (Table 1). The most frequent type of OFC was CLP (69%). Analysis of cleft type by sex showed that CLP was more frequent in males, whereas Cleft Palate (CP) occurred more often in females (Table 2). The majority of CLP cases were left-sided (55.3%). Seventy two percentage of cases occurred as NSF, and 20% had a recognized-syndrome (Table 3). The most frequently identified syndromes were Aarskog-Scott and Velocardiofacial (Table 4). Among the 288 (92.6%) of patients who had an additional congenital defect, musculoskeletal, cardiovascular, urogenital and nervous systems were the most common types. Among children 79.0% showed at least a morbidity (Table 3).
Table 2.

Cleft type distribution according to sex.

VariableFemaleMaleTotal
CL13720
CL±A448
CLP91125216
CP±A134
CP412263
TOTAL150161311

CL= cleft lip; CL±A= cleft lip with or without cleft alveolus; CLP= cleft lip and palate; CP±A= cleft palate with or without cleft alveolus; CP= cleft palate

Table 3.

Frequency of clinical forms, congenital anomalies with orofacial clefts and morbidities in Children and Adults∗

Variables n%
Clinical formsMMF289.0
NSF22472.0
SF5919.0
Total311
Birth according to clinical form in children
Term birthMMF2111.0
NSF13770.0
SF3719.0
Total195
Preterm birth
MMF34.0
NSF4873.0
SF1523.0
Total66
Morbidities
Children (<18 yrs)04080.0
1510.0
2510.0
≥3 0
Total50
Adults (18 ≥yrs)
014154.0
16525.0
23814.6
≥3 176.4
Total261
Associated congenital anomalies with orofacial clefts
System or organ
Nervous278.7
Eye103.2
Cardiovascular289.0
Urogenital278.7
Musculoskeletal16051.4
Oral Cavity123.9
Intergument247.7
No237.4
Total311

*Birth history was asked among pediatric population. Birth history is not included within Adult Medical History. Adults were not included in this analysis.

MMF= Multiple malformation form; NSF= Non-syndromic form; SF= Syndromic form

Table 4.

Frequency of syndromes associated to orofacial clefts

Code Mendelian Inheritance in Mann%
305400Aarskog-Scott 1017.0
101200Apert 11.7
601701Arthrogryposis and Ectodermal Dysplasia 1 1.7
123500Crouzon 11.7
305100Ectodermal Dysplasia and Hypohidrotic 1 35.1
129900Ectrodactily, Ectodermal Dysplasia and Cleft Lip Palate 1 11.7
129830Ectrodactyly Cleft Palate 11.7
-Fetal Alcohol11.7
164210Hemifacial Microsomia 11.7
601471Heriditary Congenital Facial Paresis 1 11.7
142900Holt-Oram 11.7
300337Hypomelanosis of Ito 11.7
-Klinefelter11.7
154700Marfan 23.4
163950Noonan 11.7
6002510Oblique Facial Clefting 111.7
311200Orofaciodigital 1 35.1
133900Orofaciodigital 5 11.7
304120Otopalatodigital 2 23.4
261800Pierre Robin 58.4
119500Popliteal Pterygyum 23.4
106600Selective Tooth Agenesis 1 11.7
117550Sotos 23.4
-Turner Syndrome11.7
192350VACTERL association 11.7
119300Van der Woude 1 35.1
192430Velocardiofacial 1017.0
Total59

Code= From OMIM, Catalog of Human Genes and Genetic Disorders

CL= cleft lip; CL±A= cleft lip with or without cleft alveolus; CLP= cleft lip and palate; CP±A= cleft palate with or without cleft alveolus; CP= cleft palate *Birth history was asked among pediatric population. Birth history is not included within Adult Medical History. Adults were not included in this analysis. MMF= Multiple malformation form; NSF= Non-syndromic form; SF= Syndromic form Code= From OMIM, Catalog of Human Genes and Genetic Disorders The distribution of preterm birth was similar among MMF, SF and NSF populations. (Table 5). The only antenatal high-risk condition that showed significant statistical association with SF was the spectrum of Hypertensive Disorders in Pregnancy (p= 0.05). Preterm birth did not show significant statistical association with SF (p= 0.67). Heart diseases, respiratory failure, seizures, and developmental dysplasia of the hip had significant statistical associations with SF (p= 0.000, p= 0.0005, p= 0.002, p= 0.0006, respectively) (Table 5) .
.

Association of SSF and NSF with antenatal high-risk conditions in Children and comorbidities among children and adults.

VariablesSSFNSF
nnTotalORp
Antenatal risk
Preterm LaborYes112
No481842323.80.3700
OligohydramniosYes167
No481792270.61.0000
HDPYes71118
No421742162.60.0500
Bleeding (unknown cause)Yes156
No481802280.71.0000
FGRYes167
No481792270.61.0000
Fetal distressYes112
No481842323.80.3700
PPRMYes123
No481832311.90.5000
Comorbidities
Respiratory infectiousYes102636
No391591981.60.3000
Gastrointestinal Tract diseasesYes71330
No421722142.20.1000
Heart diseasesYes14216
No3518321836.70.0000
DDHYes639
No431822258.50.0006
Respiratory FailureYes7714
No421782204.20.0005
Diseases of the NewbornYes61622
No431692121.50.4400
OphthalmopathyYes347
No461812272.950.1500
CMOYes42731
No451582030.50.2300
SeizuresYes8513
No4118022170.0020
Kidney and urinary tract diseasesYes224
No471832303.90.1500

SSF= syndromic form; NSF= nonsyndromic form; HDP= Hypertensive Disorders in Pregnancy; FGR= Fetal growth restriction; PPRM= Preterm premature rupture of membrane; DDH= developmental dysplasia of the hip; OR= odds ratio

SSF= syndromic form; NSF= nonsyndromic form; HDP= Hypertensive Disorders in Pregnancy; FGR= Fetal growth restriction; PPRM= Preterm premature rupture of membrane; DDH= developmental dysplasia of the hip; OR= odds ratio

Discussion

The present work is the first complete epidemiological descriptive study about Orofacial Clefts in Colombia 11,12,14. Our results are consistent with previously published studies of the distribution of OFC according to sex, affected-side and cleft type 6,7,15-17. Aarskog-Scott syndrome (AAS) shows the highest frequency among SF. This observation differs from previously published papers, which reported Van der Woude Syndrome (VDW) as the most common 6,7,18. Aarskog-Scott syndrome is an X-linked condition caused by mutations of the FGD1 gene. It is a clinically and genetically heterogeneous condition characterized by facial dysmorphic features, short stature, brachydactyly, and genital anomalies 19,20. Although clinical manifestations and diagnostic criteria are well established, diagnosis is not simple, due to the extremely variable spectrum of phenotypical features 21,22. It is probable that AAS is being underdiagnosed and for that reason the frequency according to previous studies appears lower. Further studies must be. However, geographical and ethnic factors of our population should be considered, given that they might influence the distribution of the SF with respect NSF. Research into FGD1 founder mutations might be usefully conducted in future studies. The musculoskeletal system is the most frequently affected among SF population according to this research. This result is consistent with reported findings by Calzolari et al 23. This may reflect the impact of a number of genes which play an essential role in the development of connective tissue 4,24. According to Sekhon et al25 facial anomalies are the most frequently detected, followed by ocular, central nervous system, lower and upper extremities and cardiovascular. Most of the facial, lower and upper extremities anomalies involve connective tissue. It is important to consider that the published prevalence of associated anomalies vary considerably depending on methodological factors 26. The roles of antenatal high-risk conditions among the SF population have not been well studied. Our work provides the first evidence that there is an association between SF and hypertensive disorders in pregnancy in comparison with NSF (OR= 8.5) . The etiology of SF is related to mutations within several genes involved in mesenchymal and epithelial proliferation, cell adhesion and migration and angiogenesis. All of these are essential for lip and palate development 7,27,28. The disturbance of decidua-trophoblast interactions during early human pregnancy is one of the events implicated into the pathogenesis of hypertensive disorders in pregnancy 29-31. These interactions depend largely on maternal uterine endothelial cells activated by expression of selectins that enable adherence of trophoblast to maternal endothelium 32,33, and epithelial-mesenchymal transition during trophoblast differentiation 34,35. Given the above we propose that common processes may be disrupted in both entities: 1) cell adhesion mechanisms, 2) epithelial-mesenchymal transition, and 3) angiogenesis. Transforming growth factor-beta 3 (TGF-β3), plays an essential role in these processes, and is known to be involved in the pathogenesis of hypertensive disorders in pregnancy 36-39 and some forms of OFCs 36,40. Therefore, it might be a candidate gene for both disorders. In order to test this hypothesis this gene should be investigated in patients and their mothers affected by SF and preeclampsia respectively. Associations of SF and developmental dysplasia of the hip (DDH) have not been reported in previous papers. The etiology of DDH is multifactorial, but has a considerable genetic component 41,42. Although oligohydramnios is a risk condition associated with DDH, the relationship between SF and oligohydramnios does not show significant statistical association according to this work. The causality relationships underlying this finding must be investigated with regard to the possibility of earlier hip screening among this population. Desalu et al. 43, reported that anatomical abnormalities associated with cleft lip and palate increase the risk of airway complications and this is confirmed by comparing SF and NSF in the current study (OR= 4.2). Clinical features such as micrognathia 44 and congenital heart diseases are common in SF; these factors might be involved in this association. Preterm birth and other antenatal high-risk conditions do not show significant statistical association with SF, probably due to limited power given the small set of observations. The associations found in this study contribute to appropriate medical and risk management of the affected patients. Clinicians can be guided by this study in order to provide comprehensive care for the benefit of these patients and their families. Based on the findings of this work, we are performing molecular diagnosis of the SF cases. Establishing causality relationships between the studied variables is one of the central goals of our future studies.

Conclusion

These data provide an epidemiological reference of Orofacial Clefts in Colombia. Novel associations between syndromic forms and clinical variables are determined. In order to investigate causality relationships between these variables further studies must be carried out.
  40 in total

Review 1.  Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia.

Authors:  Peter Kaufmann; Simon Black; Berthold Huppertz
Journal:  Biol Reprod       Date:  2003-03-05       Impact factor: 4.285

Review 2.  Epithelial-mesenchymal transition during trophoblast differentiation.

Authors:  L Vićovac; J D Aplin
Journal:  Acta Anat (Basel)       Date:  1996

3.  Association between homeobox-containing gene MSX1 and the occurrence of limb deficiency.

Authors:  S J Hwang; T H Beaty; I McIntosh; T Hefferon; S R Panny
Journal:  Am J Med Genet       Date:  1998-02-03

4.  Associated malformations in infants with cleft lip and palate: a prospective, population-based study.

Authors:  Josef Milerad; Ola Larson; Catherina Hagberg; Margareta Ideberg
Journal:  Pediatrics       Date:  1997-08       Impact factor: 7.124

Review 5.  Oral clefts with associated anomalies: methodological issues.

Authors:  Diego F Wyszynski; Andrea Sárközi; Andrew E Czeizel
Journal:  Cleft Palate Craniofac J       Date:  2006-01

6.  Maternal and fetal variants in the TGF-beta3 gene and risk of pregnancy-induced hypertension in a predominantly Latino population.

Authors:  Melissa L Wilson; Daniel H Desmond; T Murphy Goodwin; David A Miller; Sue Ann Ingles
Journal:  Am J Obstet Gynecol       Date:  2009-07-22       Impact factor: 8.661

7.  Role of TGF-beta in RA-induced cleft palate in CD-1 mice.

Authors:  S J Degitz; D Morris; G L Foley; B M Francis
Journal:  Teratology       Date:  1998-11

8.  Descriptive epidemiology of cleft lip and cleft palate in Western Australia.

Authors:  Jane C Bell; Camille Raynes-Greenow; Carol Bower; Robin M Turner; Christine L Roberts; Natasha Nassar
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-02-01

9.  Epidemiology of oral clefts in a large South American sample.

Authors:  B G Menegotto; F M Salzano
Journal:  Cleft Palate Craniofac J       Date:  1991-10

10.  Human stem cell cultures from cleft lip/palate patients show enrichment of transcripts involved in extracellular matrix modeling by comparison to controls.

Authors:  Daniela Franco Bueno; Daniele Yumi Sunaga; Gerson Shigeru Kobayashi; Meire Aguena; Cassio Eduardo Raposo-Amaral; Cibele Masotti; Lucas Alvizi Cruz; Peter Lees Pearson; Maria Rita Passos-Bueno
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.